Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

25 Years of RET Mutations in MEN2: What Have We Learned?

Browse by: Sort by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Chair
Gilbert J Cote, PHD
MD Anderson Cancer Ctr, Houston, TX
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
How do Activating Mutations of the RET Signaling Pathway Cause Transformation: Therapeutic Implications
Robert F Gagel, MD
MD Anderson Cancer Ctr, Houston, TX
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
Balancing Benefits and Risks of Surgical Treatment of Patients with MEN2
Samuel A Wells, MD
Washington Univ Schl of Med, Saint Louis, MO
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
What Can We Expect from Targeted Therapy?
Rossella Elisei, MD
Univ of Pisa, Pisa, Italy
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
Quality of Life and Coping with MEN2
Ana Oliveira Hoff, MD
ICESP/Univ of Sao Paulo, Sao Paulo, Brazil
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5